1. Search Result

Search Result

Results for "1176758-04-5" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-109097


    MMP iGluR Neurological Disease
    Otaplimastat (SP-8203), a matrix metalloproteinase (MMP) inhibitor, blocks N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity in a competitive manner. Otaplimastat also exhibits anti-oxidant activity. Otaplimastat can be used for the research of brain ischemic injury.